SWIVEL: A randomized phase II trial of switching medications versus guideline-directed interventions for adjuvant aromatase inhibitor side effects in breast cancer patients.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Dartmouth Cancer Center
OpenAlex ID: W7162694239